LIGAND PHARMACEUTICALS
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified,... and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation, and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management, and commercialization) to ultimately generate Ligand revenue.
LIGAND PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1987-09-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ligand.com
Total Employee:
101+
Status:
Active
Contact:
858-550-7500
Email Addresses:
[email protected]
Total Funding:
875 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache Microsoft Exchange Online
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-09-10 | xCella Biosciences | xCella Biosciences acquired by Ligand Pharmaceuticals | 7 M USD |
| 2020-09-10 | Taurus Biosciences | Taurus Biosciences acquired by Ligand Pharmaceuticals | 5 M USD |
| 2020-08-10 | Pfenex | Pfenex acquired by Ligand Pharmaceuticals | 438 M USD |
| 2020-02-11 | Icagen - Core Assets, Partnered Programs And ION Channel Technologies | Icagen - Core Assets, Partnered Programs And ION Channel Technologies acquired by Ligand Pharmaceuticals | 15 M USD |
| 2019-07-23 | Ab Initio Biotherapeutics | Ab Initio Biotherapeutics acquired by Ligand Pharmaceuticals | 12 M USD |
| 2018-08-09 | Vernalis | Vernalis acquired by Ligand Pharmaceuticals | 43 M USD |
| 2017-10-04 | Crystal Bioscience | Crystal Bioscience acquired by Ligand Pharmaceuticals | 35.5 M USD |
| 2015-12-18 | OMT | OMT acquired by Ligand Pharmaceuticals | 178 M USD |
| 2015-05-11 | Selexis | Selexis acquired by Ligand Pharmaceuticals | 4 M USD |
| 2011-01-27 | CyDex Pharmaceuticals | CyDex Pharmaceuticals acquired by Ligand Pharmaceuticals | N/A |
Investors List
Venrock
Venrock investment in Seed Round - Ligand Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-28 | Palvella Therapeutics | Ligand Pharmaceuticals investment in Series C - Palvella Therapeutics | 45 M USD |
| 2019-02-05 | Dianomi Therapeutics | Ligand Pharmaceuticals investment in Corporate Round - Dianomi Therapeutics | 3 M USD |
| 2018-12-18 | Palvella Therapeutics | Ligand Pharmaceuticals investment in Corporate Round - Palvella Therapeutics | 10 M USD |
| 2014-05-26 | Viking Therapeutics | Ligand Pharmaceuticals investment in Debt Financing - Viking Therapeutics | 2.5 M USD |
Official Site Inspections
http://www.ligand.com Semrush global rank: 2.67 M Semrush visits lastest month: 6.27 K
- Host name: 172.67.155.54
- IP address: 172.67.155.54
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ligand Pharmaceuticals"
Ligand Pharmaceuticals - Wikipedia
Ligand Pharmaceuticals' business is the acquisition of royalty rights to commercially available and in-development pharmaceutical products. In 2024, the company's portfolio contained approximately 90 therapies and drugs. Ligand is entitled to royalties on the following products: • Filspari, a non-immunosuppressive therapy for primary immunoglobulin A nephropathy See details»
Ligand Pharmaceuticals (LGND) Company Profile, History, …
Company Overview Ligand Pharmaceuticals Inc. (LGND) is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover …See details»
Ligand Pharmaceuticals - LinkedIn
Ligand Pharmaceuticals Biotechnology Research Jupiter, Florida 7,972 followers A biopharma royalty aggregrator that invests in highly differentiated …See details»
Ligand Pharmaceuticals Incorporated (LGND)
May 8, 2017 See the company profile for Ligand Pharmaceuticals Incorporated (LGND) including business summary, industry/sector information, number of employees, business …See details»
Ligand Pharmaceuticals Company Profile - Craft
Oct 29, 2024 Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. It …See details»
Ligand Pharmaceuticals - Crunchbase Company Profile …
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.See details»
About Us - Ligand Pharmaceuticals
Investors working at the intersection of development and commercialization. Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and …See details»
Ligand Pharmaceuticals - Org chart | The Org
Explore Ligand Pharmaceuticals' organizational chart. Discover current team members including executives, board members, and advisors.See details»
Ligand Pharmaceuticals Incorporated - Investor Relations
6 days ago Corporate Overview Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and …See details»
Contact - Ligand Pharmaceuticals
Contact Us Headquarters: 555 Heritage Drive Suite 200 Jupiter, FL 33458 (858) 550-7500 3911 Sorrento Valley Blvd. Suite 110 San Diego, CA 92121 800 Boylston StreetSuite 710Boston, …See details»
Ligand Pharmaceuticals Incorporated - Governance
IR Contact [email protected] Email Alerts News Events & Presentations Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote SubmitSee details»
Our Approach - Ligand Pharmaceuticals
At Ligand, we seek to identify high-value, risk-mitigated biopharmaceutical assets. We take a systematic and disciplined approach to investing to create a diversified portfolio of programs …See details»
Ligand Pharmaceuticals Incorporated - Resources - FAQs
At Ligand Pharmaceuticals Incorporated, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts …See details»
Team - Ligand Pharmaceuticals
A cross-disciplinary team with expertise in clinical development and royalty investing. Leadership Board of DirectorsSee details»
Ligand
Welcome to our company’s website. We are an integrated contract research organization with a clinical site. The name of our company is Ligand Research, which reflects our mission. A …See details»
Mission Statement, Vision, & Core Values (2025) of Ligand ...
Ligand Pharmaceuticals 2025: Mission, Vision, and Core Values Explained. Discover the driving forces behind Ligands goals for 2025 and beyond.See details»
A Fresh Look at Ligand Pharmaceuticals (LGND) Valuation …
4 days ago If you have been watching Ligand Pharmaceuticals (LGND), the $400 million convertible note offering completed this month might have made you sit up and pay attention. …See details»
Ligand to Ring the Nasdaq Opening Bell on May 19, 2025
JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) - Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market …See details»
Ligand and Medtronic Commit $70 Million in Strategic Capital to ...
Jul 31, 2025 • Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private …See details»
Ligands - Chemistry LibreTexts
The ligand is said to be "pre-organized" for binding, and there is little entropy penalty for wrapping it around the metal ion. For example heme b is a tetradentate cyclic ligand that strongly …See details»